Descriptive epidemiology of cholangiocarcinoma in Italy

Blechacz, 2008, Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment, Hepatology, 48, 308, 10.1002/hep.22310 Blechacz, 2008, Cholangiocarcinoma, Clin Liver Dis, 12, 131, 10.1016/j.cld.2007.11.003 Khan, 2007, Cholangiocarcinoma and its management, Gut, 56, 1755, 10.1136/gut.2007.138859 Patel, 2007, Cholangiocarcinoma: emerging approaches to a challenging cancer, Curr Opin Gastroenterol, 23, 317, 10.1097/MOG.0b013e3280495451 Yachimski, 2008, Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients, J Clin Gastroenterol, 42, 178, 10.1097/MCG.0b013e31806daf89 Alvaro, 2008, New insights on the molecular and cell biology of human cholangiopathies, Mol Aspects Med, 29, 50, 10.1016/j.mam.2007.09.007 Alvaro, 2007, Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver, Gastroenterology, 132, 415, 10.1053/j.gastro.2006.07.023 Boberg, 2002, Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation, Scand J Gastroenterol, 37, 1205, 10.1080/003655202760373434 Burak, 2004, Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis, Am J Gastroenterol, 99, 523, 10.1111/j.1572-0241.2004.04067.x Kaczynski, 1998, Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma—a study of 51 cases from a low-endemicity area, Acta Oncol, 37, 77, 10.1080/028418698423212 Pardi, 2003, Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis, Gastroenterology, 124, 889, 10.1053/gast.2003.50156 Stiehl, 2002, Development of dominant bile duct stenoses in patient with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment, J Hepatol, 36, 151, 10.1016/S0168-8278(01)00251-3 Olsson, 2005, High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized controlled study, Gastroenterology, 129, 1464, 10.1053/j.gastro.2005.08.017 Brandsaeter, 2004, Liver transplantation for primary slerosing cholangitis; predictors and consequences of hepatobiliary malignancy, J Hepatol, 40, 815, 10.1016/j.jhep.2004.01.002 Parkin, 1991, Liver cancer in Thailand. I. A case control study of cholangicarcinoma, Int J Cancer, 48, 323, 10.1002/ijc.2910480302 Hansel, 2003, Identification of novel cellular targets in biliary tract cancers using global gene expression technology, Am J Pathol, 163, 217, 10.1016/S0002-9440(10)63645-0 Obama, 2005, Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma, Hepatology, 41, 1339, 10.1002/hep.20718 Jinawath, 2006, Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma, J Hepatol, 44, 1025, 10.1002/hep.21330 Patel, 2001, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, 33, 1353, 10.1053/jhep.2001.25087 McGlynn, 2006, A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States, Cancer Epidemiol Biomarkers Prev, 15, 1198, 10.1158/1055-9965.EPI-05-0811 Welzel, 2006, Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States, J Natl Cancer Inst, 98, 873, 10.1093/jnci/djj234 Shaib, 2004, Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?, J Hepatol, 40, 472, 10.1016/j.jhep.2003.11.030 Wood, 2003, Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland, Eur J Cancer, 39, 2087, 10.1016/S0959-8049(03)00544-6 Patel, 2002, Worldwide trends in mortality from biliary tract malignancies, BMC Cancer, 3, 10, 10.1186/1471-2407-2-10 West, 2006, Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001, Br J Cancer, 94, 1751, 10.1038/sj.bjc.6603127 Jepsen, 2007, Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002, J Natl Cancer Inst, 99, 895, 10.1093/jnci/djk201 Alvaro, 2007, Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis, Ann Intern Med, 147, 451, 10.7326/0003-4819-147-7-200710020-00003 Alvaro, 2009, Serum and bile biomarkers for cholangiocarcinoma, Curr Opin Gastroenterol, 25, 279, 10.1097/MOG.0b013e328325a894 El-Serag, 2009, Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans, Hepatology, 49, 116, 10.1002/hep.22606 Lee, 2008, Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study, Am J Gastroenterol, 103, 1716, 10.1111/j.1572-0241.2008.01796.x Höblinger, 2008, Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers, Curr Opin Gastroenterol, 24, 363, 10.1097/MOG.0b013e3282f79b32